MicroRNA-31 is a positive modulator of endothelial-mesenchymal transition and associated secretory phenotype induced by TGF-β

Genes to Cells

Volumn 21, Issue 1, 2016, Pages 99-116

  Katsura, Akihiro ^a   Suzuki, Hiroshi I ^a,b   Ueno, Toshihide ^a   Mihira, Hajime ^a   Yamazaki, Tomoko ^a   Yasuda, Takahiko ^a   Watabe, Tetsuro ^a,c   Mano, Hiroyuki ^a   Yamada, Yoshitsugu ^a   Miyazono, Kohei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA SMOOTH MUSCLE ACTIN; CXCL16 CHEMOKINE; CYTOKINE; FRACTALKINE; INTERLEUKIN 6; MICRORNA 31; PROTEIN ANGPTL2; PROTEIN SERINE THREONINE KINASE; PROTEIN VAV3; REGULATOR PROTEIN; SERINE THREONINE KINASE 40; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; MICRORNA; MIRN31 MICRORNA, MOUSE; MKL1 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR; VAV PROTEIN; VAV3 PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ALPHA SMOOTH MUSCLE ACTIN GENE; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; ENDOTHELIAL MESENCHYMAL TRANSITION; GENE; MRTF A GENE; PHENOTYPE; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SM22ALPHA GENE; ANIMAL; CELL LINE; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; MESODERM; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; SECRETION (PROCESS); SECRETORY PATHWAY;

3' UNTRANSLATED REGIONS; ACTINS; ANIMALS; BASE SEQUENCE; CELL LINE; ENDOTHELIAL CELLS; ENDOTHELIUM; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; MESODERM; MICE; MICRORNAS; MOLECULAR SEQUENCE DATA; PHENOTYPE; POLYADENYLATION; PROTO-ONCOGENE PROTEINS C-VAV; SECRETORY PATHWAY; TRANS-ACTIVATORS; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84955365536     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/gtc.12323     Document Type: Article

References (60)

1. Borsig, L., Wolf, M.J., Roblek, M., Lorentzen, A. & Heikenwalder, M. (2014) Inflammatory chemokines and metastasis-tracing the accessory. Oncogene 33, 3217-3224.
2. Bustelo, X.R. (2000) Regulatory and signaling properties of the Vav family. Mol. Cell. Biol. 20, 1461-1477.
3. Carvajal-Gonzalez, J.M., Mulero-Navarro, S., Roman, A.C., Sauzeau, V., Merino, J.M., Bustelo, X.R. & Fernandez-Salguero, P.M. (2009) The dioxin receptor regulates the constitutive expression of the vav3 proto-oncogene and modulates cell shape and adhesion. Mol. Biol. Cell 20, 1715-1727.
4. Cooley, B.C., Nevado, J., Mellad, J. et al. (2014) TGF-beta signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci. Transl. Med. 6, 227ra234.
5. De Craene, B. & Berx, G. (2013) Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13, 97-110.
6. Erhard, F., Haas, J., Lieber, D., Malterer, G., Jaskiewicz, L., Zavolan, M., Dolken, L. & Zimmer, R. (2014) Widespread context dependency of microRNA-mediated regulation. Genome Res. 24, 906-919.
7. Ghosh, A.K., Nagpal, V., Covington, J.W., Michaels, M.A. & Vaughan, D.E. (2012) Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT. Cell. Signal. 24, 1031-1036.
8. Gingery, A., Bradley, E.W., Pederson, L., Ruan, M., Horwood, N.J. & Oursler, M.J. (2008) TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival. Exp. Cell Res. 314, 2725-2738.
9. Gregory, P.A., Bert, A.G., Paterson, E.L., Barry, S.C., Tsykin, A., Farshid, G., Vadas, M.A., Khew-Goodall, Y. & Goodall, G.J. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601.
10. Grimson, A., Farh, K.K., Johnston, W.K., Garrett-Engele, P., Lim, L.P. & Bartel, D.P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105.
11. Guo, H., Ingolia, N.T., Weissman, J.S. & Bartel, D.P. (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840.
12. Ha, M. & Kim, V.N. (2014) Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 15, 509-524.
13. Haraguchi, T., Ozaki, Y. & Iba, H. (2009) Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res. 37, e43.
14. Hashimoto, N., Phan, S.H., Imaizumi, K., Matsuo, M., Nakashima, H., Kawabe, T., Shimokata, K. & Hasegawa, Y. (2010) Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 43, 161-172.
15. Huang da, W., Sherman, B.T. & Lempicki, R.A. (2009a) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13.
16. Huang da, W., Sherman, B.T. & Lempicki, R.A. (2009b) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57.
17. Kadomatsu, T., Endo, M., Miyata, K. & Oike, Y. (2014) Diverse roles of ANGPTL2 in physiology and pathophysiology. Trends Endocrinol. Metab. 25, 245-254.
18. Kardassis, D., Murphy, C., Fotsis, T., Moustakas, A. & Stournaras, C. (2009) Control of transforming growth factor beta signal transduction by small GTPases. FEBS J. 276, 2947-2965.
19. Krenning, G., Moonen, J.R., van Luyn, M.J. & Harmsen, M.C. (2008) Vascular smooth muscle cells for use in vascular tissue engineering obtained by endothelial-to-mesenchymal transdifferentiation (EnMT) on collagen matrices. Biomaterials 29, 3703-3711.
20. Kumarswamy, R., Volkmann, I., Jazbutyte, V., Dangwal, S., Park, D.H. & Thum, T. (2012) Transforming growth factor-beta-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21. Arterioscler. Thromb. Vasc. Biol. 32, 361-369.
21. Lagendijk, A.K., Goumans, M.J., Burkhard, S.B. & Bakkers, J. (2011) MicroRNA-23 restricts cardiac valve formation by inhibiting Has2 and extracellular hyaluronic acid production. Circ. Res. 109, 649-657.
22. Laurila, E.M. & Kallioniemi, A. (2013) The diverse role of miR-31 in regulating cancer associated phenotypes. Genes Chromosom. Cancer 52, 1103-1113.
23. LeBleu, V.S., Taduri, G., O'Connell, J., Teng, Y., Cooke, V.G., Woda, C., Sugimoto, H. & Kalluri, R. (2013) Origin and function of myofibroblasts in kidney fibrosis. Nat. Med. 19, 1047-1053.
24. Li, T., Luo, W., Liu, K., Lv, X. & Xi, T. (2015) miR-31 promotes proliferation of colon cancer cells by targeting E2F2. Biotechnol. Lett. 37, 523-532.
25. Maddaluno, L., Rudini, N., Cuttano, R. et al. (2013) EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498, 492-496.
26. Maleszewska, M., Moonen, J.R., Huijkman, N., van de Sluis, B., Krenning, G. & Harmsen, M.C. (2013) IL-1beta and TGFbeta2 synergistically induce endothelial to mesenchymal transition in an NFkappaB-dependent manner. Immunobiology 218, 443-454.
27. Matsuyama, H., Suzuki, H.I., Nishimori, H., Noguchi, M., Yao, T., Komatsu, N., Mano, H., Sugimoto, K. & Miyazono, K. (2011) miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma. Blood 118, 6881-6892.
28. Medici, D., Potenta, S. & Kalluri, R. (2011) Transforming growth factor-beta2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochem. J. 437, 515-520.
29. Mihira, H., Suzuki, H.I., Akatsu, Y., Yoshimatsu, Y., Igarashi, T., Miyazono, K. & Watabe, T. (2012) TGF-beta-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A. J. Biochem. 151, 145-156.
30. Mishalian, I., Bayuh, R., Eruslanov, E., Michaeli, J., Levy, L., Zolotarov, L., Singhal, S., Albelda, S.M., Granot, Z. & Fridlender, Z.G. (2014) Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17-a new mechanism of impaired antitumor immunity. Int. J. Cancer 135, 1178-1186.
31. Mizoguchi, F., Murakami, Y., Saito, T., Miyasaka, N. & Kohsaka, H. (2013) miR-31 controls osteoclast formation and bone resorption by targeting RhoA. Arthritis. Res. Ther. 15, R102.
32. Nam, D.K., Lee, S., Zhou, G., Cao, X., Wang, C., Clark, T., Chen, J., Rowley, J.D. & Wang, S.M. (2002) Oligo(dT) primer generates a high frequency of truncated cDNAs through internal poly(A) priming during reverse transcription. Proc. Natl Acad. Sci. USA 99, 6152-6156.
33. Nam, J.W., Rissland, O.S., Koppstein, D., Abreu-Goodger, C., Jan, C.H., Agarwal, V., Yildirim, M.A., Rodriguez, A. & Bartel, D.P. (2014) Global analyses of the effect of different cellular contexts on microRNA targeting. Mol. Cell 53, 1031-1043.
34. Nicoloso, M.S., Spizzo, R., Shimizu, M., Rossi, S. & Calin, G.A. (2009) MicroRNAs-the micro steering wheel of tumour metastases. Nat. Rev. Cancer 9, 293-302.
35. Pedrioli, D.M., Karpanen, T., Dabouras, V., Jurisic, G., van de Hoek, G., Shin, J.W., Marino, D., Kalin, R.E., Leidel, S., Cinelli, P., Schulte-Merker, S., Brandli, A.W. & Detmar, M. (2010) miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo. Mol. Cell. Biol. 30, 3620-3634.
36. Potenta, S., Zeisberg, E. & Kalluri, R. (2008) The role of endothelial-to-mesenchymal transition in cancer progression. Br. J. Cancer 99, 1375-1379.
37. Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P.P. (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353-358.
38. Suarez, Y., Wang, C., Manes, T.D. & Pober, J.S. (2010) Cutting edge: TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J. Immunol. 184, 21-25.
39. Suzuki, H.I., Arase, M., Matsuyama, H., Choi, Y.L., Ueno, T., Mano, H., Sugimoto, K. & Miyazono, K. (2011) MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. Mol. Cell 44, 424-436.
40. Suzuki, H.I., Katsura, A., Yasuda, T., Ueno, T., Mano, H., Sugimoto, K. & Miyazono, K. (2015) Small-RNA asymmetry is directly driven by mammalian Argonautes. Nat. Struct. Mol. Biol. 22, 512-521.
41. Suzuki, H.I., Matsuyama, H., Noguchi, M., Yao, T., Komatsu, N., Mano, H., Sugimoto, K. & Miyazono, K. (2013a) Computational dissection of distinct microRNA activity signatures associated with peripheral T cell lymphoma subtypes. Leukemia 27, 2107-2111.
42. Suzuki, H.I., Mihira, H., Watabe, T., Sugimoto, K. & Miyazono, K. (2013b) Widespread inference of weighted microRNA-mediated gene regulation in cancer transcriptome analysis. Nucleic Acids Res. 41, e62.
43. Suzuki, H.I. & Miyazono, K. (2010) Dynamics of microRNA biogenesis: crosstalk between p53 network and microRNA processing pathway. J. Mol. Med. (Berl) 88, 1085-1094.
44. Suzuki, H.I. & Miyazono, K. (2011) Emerging complexity of microRNA generation cascades. J. Biochem. 149, 15-25.
45. Suzuki, H.I., Yamagata, K., Sugimoto, K., Iwamoto, T., Kato, S. & Miyazono, K. (2009) Modulation of microRNA processing by p53. Nature 460, 529-533.
46. Trapnell, C., Pachter, L. & Salzberg, S.L. (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111.
47. Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D.R., Pimentel, H., Salzberg, S.L., Rinn, J.L. & Pachter, L. (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562-578.
48. Wang, J., Yan, C.H., Li, Y., Xu, K., Tian, X.X., Peng, C.F., Tao, J., Sun, M.Y. & Han, Y.L. (2013) MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes. Exp. Cell Res. 319, 1165-1175.
49. Weber, C., Meiler, S., Doring, Y. et al. (2011) CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice. J. Clin. Invest. 121, 2898-2910.
50. Wylie-Sears, J., Levine, R.A. & Bischoff, J. (2014) Losartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-beta-induced phosphorylation of ERK. Biochem. Biophys. Res. Commun. 446, 870-875.
51. Xiao, L., Kim, D.J., Davis, C.L., McCann, J.V., Dunleavey, J.M., Vanderlinden, A.K., Xu, N., Pattenden, S.G., Frye, S.V., Xu, X., Onaitis, M., Monaghan-Benson, E., Burridge, K. & Dudley, A.C. (2015) Tumor Endothelial Cells with Distinct Patterns of TGFbeta-Driven Endothelial-to-Mesenchymal Transition. Cancer Res. 75, 1244-1254.
52. Xu, N., Meisgen, F., Butler, L.M., Han, G., Wang, X.J., Soderberg-Naucler, C., Stahle, M., Pivarcsi, A. & Sonkoly, E. (2013) MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J. Immunol. 190, 678-688.
53. Xu, X., Huang, P., Yang, B., Wang, X. & Xia, J. (2014) Roles of CXCL5 on migration and invasion of liver cancer cells. J. Transl. Med. 12, 193.
54. Yagi, K., Furuhashi, M., Aoki, H., Goto, D., Kuwano, H., Sugamura, K., Miyazono, K. & Kato, M. (2002) c-myc is a downstream target of the Smad pathway. J. Biol. Chem. 277, 854-861.
55. Yan, S., Xu, Z., Lou, F. et al. (2015) NF-kappaB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Nat. Commun. 6, 7652.
56. Yoshimatsu, Y. & Watabe, T. (2011) Roles of TGF-beta signals in endothelial-mesenchymal transition during cardiac fibrosis. Int. J. Inflam. 2011, 724080.
57. Zeisberg, E.M., Potenta, S., Xie, L., Zeisberg, M. & Kalluri, R. (2007) Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 67, 10123-10128.
58. Zhang, L., Ke, F., Liu, Z. et al. (2015a) MicroRNA-31 negatively regulates peripherally derived regulatory T-cell generation by repressing retinoic acid-inducible protein 3. Nat. Commun. 6, 7639.
59. Zhang, Z., Zhang, T., Zhou, Y., Wei, X., Zhu, J., Zhang, J. & Wang, C. (2015b) Activated phosphatidylinositol 3-kinase/akt inhibits the transition of endothelial progenitor cells to mesenchymal cells by regulating the forkhead box subgroup o-3a signaling. Cell. Physiol. Biochem. 35, 1643-1653.
60. Zhu, K., Pan, Q., Jia, L.Q., Dai, Z., Ke, A.W., Zeng, H.Y., Tang, Z.Y., Fan, J. & Zhou, J. (2014) MiR-302c inhibits tumor growth of hepatocellular carcinoma by suppressing the endothelial-mesenchymal transition of endothelial cells. Sci. Rep. 4, 5524.